Term Name: GDC-0623
Synonyms: 5-(2-fluoro-4-iodoanilino)-N-(2-hydroxyethoxy)imidazo[1,5-a]pyridine-6-carboxamide, 5-[(2-fluoro-4-iodophenyl)amino]-N-(2-hydroxyethoxy)imidazo[1,5-a]pyridine-6-carboxamide, G 868, G-868, G868, GDC 0623, GDC0623, RG 7421, RG-7421
Definition: A member of the class of imidazopyridines that is imidazo[1,5-a]pyridine substituted by (2-fluoro-4-iodophenyl)amino and (2-hydroxyethoxy)aminoacyl groups at positions 5 and 6. It is a potent ATP non-competitive inhibitor of MEK1 (Ki = 0.13nM) and also has efficacy against both mutant BRAF and mutant KRAS. It is in clinical development for treatment of patients with locally advanced or metastatic solid tumors.
Ontology: ChEBI [CHEBI:167659]  ( EBI )

Relationships
is a type of: hydroxamic acid ester imidazopyridine monofluorobenzenes organoiodine compound primary alcohol secondary amino compound substituted aniline
has_role: antineoplastic agent apoptosis inducer EC 2.7.12.2 (mitogen-activated protein kinase kinase) inhibitor